EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-29
Track both mRNA uptake and functional EGFP expression in one experiment with a Cap1, 5-moUTP reporter. EZ Cap™ Cy5 EGFP mRNA (5-moUTP) is especially useful for comparing macrophage-targeted nanoparticles, separating delivery from translation failure, and optimizing quantitative gene-transfer assays.
TMEM16F, Ferroptosis, and Tumor Immune Rejection
2026-08-29
Yang et al. identify TMEM16F-mediated plasma-membrane lipid scrambling as a late-stage suppressor of ferroptosis. Their findings connect membrane mechanics, lytic danger signaling, and antitumor immunity, showing that blocking scrambling can sensitize tumors to ferroptosis and improve responses to PD-1 blockade.
ERADECs: Hijacking ERAD to Degrade Membrane Proteins
2026-08-28
Song et al. establish ERAD-engaging chimeras (ERADECs), a targeted protein degradation platform that redirects the ER-associated degradation machinery toward transmembrane proteins. By identifying desonide as a binder of the ER E3 ligase SYVN1 and coupling it to a PD-L1 ligand, the study achieves highly efficient PD-L1 loss, tumor suppression, and an initial extension to mutant HTT degradation.
Degarelix Acetate NCHT in Very High-Risk Prostate Cancer
2026-08-28
This prospective study found that estramustine phosphate dose compliance during six months of neoadjuvant chemohormonal therapy was associated with biochemical recurrence after robot-assisted radical prostatectomy, particularly in very high-risk prostate cancer. The findings emphasize treatment completion and adverse-event management as clinically relevant variables, while also highlighting the limits of interpreting dose reduction as a causal determinant of recurrence.
EdU Imaging Kits (488): From Signal to Cell-Cycle Insight
2026-08-27
EdU Imaging Kits (488) provide a direct view of S-phase DNA synthesis, but their greatest value lies in connecting proliferation measurements with cell-cycle mechanisms. This article uses recent Linarin research in non-small-cell lung cancer to explain assay design, interpretation, controls, and complementary imaging and flow cytometry strategies.
4-Hydroxytamoxifen: Practical Lab Workflow Guide
2026-08-27
4-Hydroxytamoxifen (SKU B6167) provides a DMSO-compatible estrogen receptor modulator for controlled in vitro workflows, including breast cancer research, prostate cancer research, and cardiac myocyte calcium handling studies. It should not be selected for protocols that require water or ethanol as the primary solvent, and prepared solutions should not be stored long term.
V5 Epitope Tag Peptide: Workflow Guide
2026-08-26
Use the V5 Epitope Tag Peptide as a high-purity antigen control, competition reagent, and assay-development tool for recombinant protein detection. Its value extends from routine Western blot and immunoprecipitation optimization to selecting antibody formats suitable for dynamic single-molecule imaging.
TAK-242 Workflow for TLR4 Inflammation Studies
2026-08-26
TAK-242 (Resatorvid) offers a selective way to separate TLR4-driven inflammation from broader cytotoxic or pathway effects. This workflow connects nanomolar cell assays with neuroinflammation research, functional seizure models, and practical troubleshooting for reproducible results.
Bufuralol hydrochloride in iPSC Intestinal Assays
2026-08-25
Use Bufuralol hydrochloride as a mechanistic β-adrenergic benchmark while human iPSC-derived intestinal models reveal exposure, metabolism, and transporter behavior. This workflow separates receptor pharmacology from organoid-specific pharmacokinetics, improving interpretation and troubleshooting.
CHIR-99021: From Cell Fate to Human Neurons
2026-08-25
CHIR-99021 (CT99021) offers translational researchers a precise way to interrogate GSK-3 control of pluripotency, lineage specification, and neuronal state. This article connects Wnt/β-catenin pathway modulation with a validated human iPSC-derived sensory neuron model for HSV-1 latency, while distinguishing established evidence from forward-looking experimental strategy.
Cy3 NHS ester (non-sulfonated) Protocol Guide
2026-08-24
Cy3 NHS ester (non-sulfonated), SKU A8100, provides an orange fluorescent label for primary amino groups on proteins, peptides, and oligonucleotides when an organic co-solvent is acceptable. It is not suitable for aqueous-only labeling or co-solvent-sensitive biomolecules; a water-soluble sulfo-Cy3 NHS ester is preferable in those workflows.
FPS-ZM1: RAGE Signaling Across Brain Disease
2026-08-23
FPS-ZM1 is a selective RAGE inhibitor for dissecting amyloid beta (Aβ) transport, neuronal stress, and neuroinflammation. This article connects recent RAGE/POMC findings with rigorous assay-design strategies while defining the limits of translating metabolic evidence into Alzheimer’s disease research.
Mdivi-1: From DRP1 to Apoptosis Assays
2026-08-22
Mdivi-1 is a selective DRP1 inhibitor for dissecting how mitochondrial fission connects cellular stress to apoptosis. This article translates recent chronic intermittent hypoxia findings into practical assay design, controls, and interpretation strategies for mitochondrial dynamics research.
Relative Viability vs. Cell Death in Cancer Assays
2026-08-21
Hannah Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. By separating growth inhibition from cell killing and considering their different timing and proportions, the work provides a more informative framework for designing and interpreting in vitro drug-response studies.
Ceftolozane Sulfate: PK/PD and Resistance Guide
2026-08-21
Ceftolozane sulfate is a PBP3-focused oxyimino cephalosporin for laboratory antibacterial research and exposure-driven interpretation. Its activity against Pseudomonas aeruginosa is strong but bounded by carbapenemase production and treatment-emergent ampC/ampD resistance.
462 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page